Results 31 to 40 of about 288,465 (306)

Psychosocial Need Analysis of Patients with Pulmonary Tuberculosis. [PDF]

, 2014
Pulmonary tuberculosis (TB) is a chronic pulmonary disease impacted on physical and psychosocial of the patients. However, to date, the goverment’s programs has not address the psychososial problem of the patients yet.
Hernawati, T. (Taty), Sriati, A. (Aat), Suryani, S. (Suryani), Widianti, E. (Efri)   +3 more
core   +2 more sources

Appendicular mass – a rare form of tuberculosis [PDF]

, 2017
Tuberculosis is in the top 10 causes of death worldwide, being one of the most deadly infectious diseases. It is estimated that one of three people from the entire earth population has a latent infection with M tuberculosis.
Balalau, Cristian, Banu, Petrisor, Bratucu, Mircea, Constantin, Vlad D., Popa, Florian, Vladescu, Teodora   +5 more
core   +4 more sources

The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis

BMC Infectious Diseases, 2023
Objective This study investigated the diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra (Ultra) for detecting smear-negative pulmonary tuberculosis (TB).
Lan Yao, Shanhao Chen, Wei Sha, Ye Gu
doaj   +1 more source

Efficacy of the Xpert Mycobacterium tuberculosis/rifampicin assay for diagnosing sputum-smear negative or sputum-scarce pulmonary tuberculosis in bronchoalveolar lavage fluid

International Journal of Infectious Diseases, 2021
Objective: To evaluate he diagnostic performance of the Xpert Mycobacterium tuberculosis/Rifampin (MTB/RIF) assay in bronchoalveolar lavage fluid (BALF).
Juan Yang, Yanheng Shen, Lei Wang, LiXia Ju, Xiaocui Wu, Peng Wang, Xiaohui Hao, Qin Sun, Fangyou Yu, Wei Sha   +9 more
doaj   +1 more source

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

Emerging Microbes and Infections, 2023
In preclinical studies, a new antituberculosis drug regimen markedly reduced the time required to achieve relapse-free cure. This study aimed to preliminarily evaluate the efficacy and safety of this four-month regimen, consisting of clofazimine ...
Xubin Zheng, Xuwei Gui, Lan Yao, Jun Ma, Yifan He, Hai Lou, Jin Gu, Ruoyan Ying, Liping Chen, Qin Sun, Yidian Liu, Chih-Ming Ho, Bai-Yu Lee, Daniel L. Clemens, Marcus A. Horwitz, Xianting Ding, Xiaohui Hao, Hua Yang, Wei Sha   +18 more
doaj   +1 more source

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control. [PDF]

, 2014
BACKGROUND: Mass drug administration (MDA) with azithromycin, carried out for the control of blinding trachoma, has been linked to reduced mortality in children.
A Amza, A Amza, A Sommer, A Weisz, AE Roth, AJ Weisz, Ansumana Sillah, C Nokes, C Panter-Brick, CG Victora, CJ Whitty, CL Coles, CL Coles, D Stare, David C W Mabey, EJ Giamarellos-Bourboulis, EK Gough, EM Harding-Esch, EM Harding-Esch, Emma M Harding-Esch, EV Basilion, I Udan, JD Keenan, JH Humphrey, John Hart, KL Kotloff, KN Ryan, L Leonor Rodríguez, LS Stephenson, Martin J Holland, MG Rowland, MG Rowland, MP Eccles, P Aaby, PG Lunn, R Goto, RL Guerrant, Robin L Bailey, S Haug, Sarah E Burr, T Edwards, Tansy Edwards, TC Porco, WHO, WHO, WHO, WHO   +46 more
core   +2 more sources

TUBERCULIN IN PULMONARY TUBERCULOSIS [PDF]

BMJ, 1911
n ...
openaire   +5 more sources

The regulation and potential role of interleukin-32 in tuberculous pleural effusion

Frontiers in Immunology
The possible protective effect of interleukin-32 (IL-32) in Mycobacterium tuberculosis (Mtb) infection has been indicated. However, few studies have been focused on IL-32 in tuberculosis patients.
Xuan Wang, Chengqing Yang, Chao Quan, Jun Li, Yan Hu, Peng Liu, Lulu Guan, Li Li, Li Li   +8 more
doaj   +1 more source

Treatment of Pulmonary Tuberculosis

Medical Clinics of North America, 1956
n ...
Sokoloff, Martin J., Boucot, Katharine R.   +1 more
openaire   +3 more sources

THE NOTIFICATION OF PULMONARY TUBERCULOSIS. [PDF]

The Lancet, 1899
n ...
Pattin, H. Cooper, Pattin, H. Cooper
openaire   +2 more sources